These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

264 related items for PubMed ID: 38495631

  • 1. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling.
    Liu J, Fang G, Lan C, Qiu C, Yao L, Zhang Q, Hu J, Zhang Y, Yang Y, Zhang Y.
    Drug Des Devel Ther; 2024; 18():767-780. PubMed ID: 38495631
    [Abstract] [Full Text] [Related]

  • 2. Thymoquinone attenuates monocrotaline-induced pulmonary artery hypertension via inhibiting pulmonary arterial remodeling in rats.
    Zhu N, Zhao X, Xiang Y, Ye S, Huang J, Hu W, Lv L, Zeng C.
    Int J Cardiol; 2016 Oct 15; 221():587-96. PubMed ID: 27420584
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol inhibits monocrotaline-induced pulmonary arterial remodeling by suppression of SphK1-mediated NF-κB activation.
    Shi W, Zhai C, Feng W, Wang J, Zhu Y, Li S, Wang Q, Zhang Q, Yan X, Chai L, Liu P, Chen Y, Li M.
    Life Sci; 2018 Oct 01; 210():140-149. PubMed ID: 30179628
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
    Zhai C, Shi W, Feng W, Zhu Y, Wang J, Li S, Yan X, Wang Q, Zhang Q, Chai L, Li C, Liu P, Li M.
    Life Sci; 2018 Sep 01; 208():87-95. PubMed ID: 30009823
    [Abstract] [Full Text] [Related]

  • 6. A urotensin II receptor antagonist, KR36676, decreases vascular remodeling and inflammation in experimental pulmonary hypertension.
    Lee JH, Park BK, Oh KS, Yi KY, Lim CJ, Seo HW, Lee BH.
    Int Immunopharmacol; 2016 Nov 01; 40():196-202. PubMed ID: 27611861
    [Abstract] [Full Text] [Related]

  • 7. Corosolic acid attenuates platelet-derived growth factor signaling in macrophages and smooth muscle cells of pulmonary arterial hypertension.
    Yamamura A, Fujiwara M, Kawade A, Amano T, Hossain A, Nayeem MJ, Kondo R, Suzuki Y, Inoue Y, Hayashi H, Suzuki S, Sato M, Yamamura H.
    Eur J Pharmacol; 2024 Jun 15; 973():176564. PubMed ID: 38614383
    [Abstract] [Full Text] [Related]

  • 8. Baicalein attenuates monocrotaline-induced pulmonary arterial hypertension by inhibiting vascular remodeling in rats.
    Shi R, Wei Z, Zhu D, Fu N, Wang C, Yin S, Liang Y, Xing J, Wang X, Wang Y.
    Pulm Pharmacol Ther; 2018 Feb 15; 48():124-135. PubMed ID: 29133079
    [Abstract] [Full Text] [Related]

  • 9. Calcineurin/NFAT Signaling Modulates Pulmonary Artery Smooth Muscle Cell Proliferation, Migration and Apoptosis in Monocrotaline-Induced Pulmonary Arterial Hypertension Rats.
    He RL, Wu ZJ, Liu XR, Gui LX, Wang RX, Lin MJ.
    Cell Physiol Biochem; 2018 Feb 15; 49(1):172-189. PubMed ID: 30134231
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of nuclear factor-κB in the lungs prevents monocrotaline-induced pulmonary hypertension in mice.
    Li L, Wei C, Kim IK, Janssen-Heininger Y, Gupta S.
    Hypertension; 2014 Jun 15; 63(6):1260-9. PubMed ID: 24614212
    [Abstract] [Full Text] [Related]

  • 11. A novel PDGFR inhibitor WQ-C-401 prevents pulmonary vascular remodeling in rats with monocrotaline-induced pulmonary arterial hypertension.
    Huang W, Zhou H, He Y, Wang A, Wang B, Chen Y, Liu C, Wang H, Xie W, Kong H.
    Exp Cell Res; 2024 Aug 01; 441(1):114154. PubMed ID: 38996959
    [Abstract] [Full Text] [Related]

  • 12. Canagliflozin inhibits PASMCs proliferation via regulating SGLT1/AMPK signaling and attenuates artery remodeling in MCT-induced pulmonary arterial hypertension.
    Chen X, Yu X, Lian G, Tang H, Yan Y, Gao G, Huang B, Luo L, Xie L.
    Biomed Pharmacother; 2024 May 01; 174():116505. PubMed ID: 38574614
    [Abstract] [Full Text] [Related]

  • 13. Betaine Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats via Inhibiting Inflammatory Response.
    Yang JM, Zhou R, Zhang M, Tan HR, Yu JQ.
    Molecules; 2018 May 26; 23(6):. PubMed ID: 29861433
    [Abstract] [Full Text] [Related]

  • 14. Pathophysiological roles of nuclear factor kappaB (NF-kB) in pulmonary arterial hypertension: effects of synthetic selective NF-kB inhibitor IMD-0354.
    Hosokawa S, Haraguchi G, Sasaki A, Arai H, Muto S, Itai A, Doi S, Mizutani S, Isobe M.
    Cardiovasc Res; 2013 Jul 01; 99(1):35-43. PubMed ID: 23631839
    [Abstract] [Full Text] [Related]

  • 15. 5-Aminosalicylic Acid Attenuates Monocrotaline-Induced Pulmonary Arterial Hypertension in Rats by Increasing the Expression of Nur77.
    Sun LY, Cai ZY, Pu J, Li J, Shen JY, Yang CD, He B.
    Inflammation; 2017 Jun 01; 40(3):806-817. PubMed ID: 28213866
    [Abstract] [Full Text] [Related]

  • 16. Forsythoside B Mitigates Monocrotaline-Induced Pulmonary Arterial Hypertension via Blocking the NF-κB Signaling Pathway to Attenuate Vascular Remodeling [LETTER].
    Pasiana AD, Idrus HH, Purnamasari I.
    Drug Des Devel Ther; 2024 Jun 01; 18():1023-1024. PubMed ID: 38585253
    [No Abstract] [Full Text] [Related]

  • 17. Ruscogenin exerts beneficial effects on monocrotaline-induced pulmonary hypertension by inhibiting NF-κB expression.
    Zhu R, Bi L, Kong H, Xie W, Hong Y, Wang H.
    Int J Clin Exp Pathol; 2015 Jun 01; 8(10):12169-76. PubMed ID: 26722401
    [Abstract] [Full Text] [Related]

  • 18. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
    Cheng G, Wang X, Li Y, He L.
    Stem Cell Res Ther; 2017 Feb 10; 8(1):34. PubMed ID: 28187784
    [Abstract] [Full Text] [Related]

  • 19. [NF-κB inhibitor improves pulmonary vascular remodeling by reversing LPS-induced down-regulation of BMPRII].
    Zhou MJ, Xing YJ, Yang J.
    Sheng Li Xue Bao; 2020 Oct 25; 72(5):541-550. PubMed ID: 33106824
    [Abstract] [Full Text] [Related]

  • 20. Srolo Bzhtang reduces inflammation and vascular remodeling via suppression of the MAPK/NF-κB signaling pathway in rats with pulmonary arterial hypertension.
    Chen T, Su S, Yang Z, Zhang D, Li Z, Lu D.
    J Ethnopharmacol; 2022 Oct 28; 297():115572. PubMed ID: 35872290
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.